OneMedNet Reports Over 25% Expansion of iRWD™ Network, Encompassing Clinical Data alongside Aggregate Health Economics and Social Determinant Insights from 5 Billion Administrative Records, Fueling Growth in AI-Powered Healthcare Data
Over 1,750 provider sites and access to 136 million clinical exams positions OneMedNet for accelerated revenue and market penetration
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced today a greater than 25% expansion of its proprietary iRWD™ network and platform, underscoring the Company’s strategic execution and market responsiveness. This milestone significantly enhances the Company's reach, operational capacity, and growth trajectory – including the addition of over 5 billion administrative records that support aggregated health economics research and insights into social determinants of health.
Driven by the rising demand for high-quality longitudinal data, rare disease insights, and datasets that include health economics and social determinants of health, OneMedNet has rapidly accelerated the development of new partner sites across its nationwide network. This expansion also responds to the growing need for inclusive data representing underserved and underrepresented populations.
As a result, OneMedNet now provides its customers with seamless access to a dramatically scaled, de-identified data network comprising the following key growth metrics:
- 25% iRWD™ network expansion
- 1750+ healthcare system and provider partner sites
- 34 million patients
- 136 million clinical exams
- 5 billion Administrative Records, inclusive of claims
- Addresses rare diseases, underserved populations, and high-demand RWD sectors by enabling insights into health economic and social determinants
- Poised for significant revenue growth through increased data licensing and new enterprise partnerships
This exponential growth not only reinforces OneMedNet’s position as a premier data partner but also lays the foundation for accelerated revenue generation, customer acquisition, and data monetization at scale.
At OneMedNet, we believe Real-World Evidence is only as powerful as the clinical integrity of the data behind it. The OneMedNet iRWD™ network and platform delivers regulatory-grade depth and precision, enabling life sciences, payers, and healthcare innovators to generate clinically grounded insights that are actionable and reflective of how care is delivered in the real world. As the $60 billion RWE industry1, continues to transform, OneMedNet is proud to be at the forefront, helping make evidence generation faster, more effective, and more grounded in real clinical reality says Aaron Green, President & CEO, OneMedNet.
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at .
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
OneMedNet Contacts:
Michael Wong, VP Marketing
Email:
SOURCE: ONEMEDNET CORPORATION
